Quality Report 2020 / 2021

Facts & figures

The Hubertus Wald Tumor Center - Universitäres Cancer Center Hamburg (UCCH) has been certified as an Oncological Center by the German Cancer Society (DKG) since 2011 . The UCCH has been recognized by the German Cancer Aid (DKH) as an Oncological Center of Excellence since 2009.


The aim of this coordinative network is to provide optimal individual tumor medical care for patients and to consistently develop clinical and translational research in the Hamburg metropolitan region. Personalized therapy concepts are offered on the basis of molecular biological analyses. In addition to therapy and research, we take care of the individual well-being of patients through numerous additional offers (e.g. music, art, sports therapy, nutrition, etc.) and have also further developed prevention and aftercare concepts.

Since 2015, we have been the first German state to implement the amended regional cancer registry law (Hamburg) with close cooperation of the clinical cancer registry at UKE, which is coordinated by UCCH. The Hamburg Cancer Registry (HKR) was founded in 1926, making it the oldest of its kind in the world.


First certification as a breast center at the UKE (DKG - Organ Cancer Center)

Foundation & start of the Universitäres Cancer Center Hamburg (UCCH) and certification by the
DGHO as an Oncological Center

Initial certification as a Prostate Center (DKG - Organ Cancer Center)

Award and start of the 1st funding period by the DKH as Oncology Center of Excellence

Overall certification of the UKE according to DIN ISO 9001 (first hospital in Germany)

Certification as a family-friendly company, as well as according to criteria on
Patient Safety and Ethics & Values

First certification as Gynecological Cancer Center (DKG - Organ Cancer Center) with certified Dysplasia Unit since 2015

Establishment of a Central Entry Port, a central administration and an outpatient clinic for all cancer patients

Initial certification as superordinate Oncological Center (DKG) with Head-Neck Tumor Center (organ cancer center)

Second honouring and founding by the DKH as an Interdisciplinary Oncological Center of Excellence

Initial certification as Colon Cancer Center (DKG - organ cancer center)

Renewed award and start of 3rd funding period by DKH as an Interdisciplinary Oncological Center of Excellence

Initial certification of the ENETS Center for Excellence - European certification as a center of excellence for neuroendocrine tumors

Initial certification as Skin Cancer Center (DKG - organ cancer center)

Initial certification Pediatric Oncology Center (DKG Organ Cancer Center)

Patient care

At the UCCH patients are cared for covering the whole range of oncological and hematological diseases. According to the treatment method (chemotherapy, radiation therapy, surgery etc.) patients are either treated stationary or in our outpatient department.

The UCCH consists of all major facilities necessary for the treatement of oncological and hematological patients and operates according to newest scientific findings and predefined treatment plans. One main focus lies on the personalized cancer medicine. Based on interdisciplinary tumor conferences and liaision services there is a close joint work with all cooperating departments and external partners in the metropolitian area of Hamburg.

  • many cancer patients of the UKE reach us via our central registration portal
  • > 30% of all patients are trans-regional
  • Palliative medical focus at the UKE with ESMO certification, recognition by the DKG and certificate of the German Society for Palliative Medicine
  • More than 30 specialized outpatient clinics for different entities (tumors)
  • 13 specialized outpatient clinics for e.g. complementary medicine, hereditary tumors, second opinion, prevention and personalized medicine UCCH Consultation overview
  • Survivorship program for patients
  • Focus on psycho-oncological care and research (> 11,000 contacts each year)
  • Close cooperation with more than 38 patient support groups

The UCCH in numbers

  • > 8,300 stationary patients and > 18,800 outpatients
  • > 7,000 new diagnoses per year
  • > 12,000 patients/year visit our consultation hours and outpatient clinics
  • > 14,000 tumor cases per year are discussed in interdisciplinary tumor conferences
  • > 3,000 patients in systematic therapies each year with > 36,000 medications

    (status 2020)

Clinical studies

  • > 2,300 UCCH patients are curently enrolled in interventional clinical trials
  • Electronic tool "Trial Finder" for quick search of internal and external open studies
  • Joint study management with cooperation partners


  • Interdisciplinary research programs for Dissemination & Metastasis, Prostate Cancer, Leukemia & Lymphoma, Neuro-oncology, Psycho-oncology, Head & Neck Cancer, Gastro-intestinal Cancer and Cancer Epidemiology
  • > 25 core facilities for experimental, clinical, translational and epidemiological cancer research
  • > 1,500 publications with the "research focus cancer" (2016-18)


  • 42 evidence-based pathways for diagnostics, therapy and follow-up care
  • 22 interdisciplinary tumor boards
  • Central units: UCCH Cancer Registry, UCCH Clinical Trial Center, Central Entry Port, UCCH Core Unit (central administration)
  • Coordination of cancer-relevant bio- and tissue repositories at the UKE
  • Regular evaluation of tumor boards decisions


>500 physicians, researchers and clinical and administrative staff in the service of cancer medicine

Executive Board

The structure of the UCCH is divided into three hierarchical layers:
1.) UCCH Executive Board,
2.) Board Council,
3.) Meeting of Members.

UCCH Executive Board


  • Hubertus Wald Foundation
  • German Cancer Aid
  • José Carreras Foundation